The Relationship Between the Continuum of Elevated Adiposity, Hyperinsulinemia, and Type 2 Diabetes and Late-onset Alzheimer’s Disease: An Epidemiological Perspective
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Diabetes and hyperinsulinemia may be risk factors for Alzheimer's disease.
“Diabetes and hyperinsulinemia may be risk factors for Alzheimer's disease (AD).”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [10]
Type 2 diabetes and its correlates and antecedents, insulin resistance and elevated adiposity, have shown strong associations with Alzheimer's disease in observational studies.
“Type 2 diabetes (T2D) and its correlates and antecedents, insulin resistance and elevated adiposity (overweight and obesity) have shown strong associations with AD in observational studies [10, 11].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [10]
The citation lists haven’t been fetched yet
References 157 · Cited by 3
- Authors
- Luchsinger, J. A.
- Venue
- Research and Perspectives in Alzheimer's Disease
- Publisher
- Springer Berlin Heidelberg
- Published
- 2010
- Pages
- 89-107
- ISSN
- 0945-6066 (ISSN-L)
- OpenAlex
- W196393649
- Cited by
- 3
- References
- 157
- Citations by year
- 2016: 2 · 2014: 1
- FWCI
- 0.00
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- Locations
- Research and perspectives in Alzheimer's disease (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- late-onset Alzheimer's disease, type 2 diabetes, hyperinsulinemia, adiposity, obesity, insulin resistance, vascular risk factors, cognitive decline, insulin sensitizers, Alzheimer's disease prevention, middle age (human life stage)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
